Company Profile
NRX Pharmaceuticals, Inc. Stock Price, News & Catalysts
- Ticker:
- NRXP
- Exchange:
- NASDAQ
- Sector:
- Biopharma
- Location:
- United States
Stock performance
3.45 USD (-3.09%)
Close
Last updated: August 24, 2026
167M USD
Market cap
Why the stock is moving
As of Aug 24, 2026, NRXP closed down 3.09% at $3.45. No new same-company headline was identified in the current news window.
Company overview
Business overview
NRX Pharmaceuticals is a neuroscience and psychiatric-care company focused on severe depression and related central nervous system conditions. Its story has centered on hard-to-treat mental-health disorders.
Geographic Base and Sector Classification
Headquartered in the United States and listed on NASDAQ, NRX sits in specialty biotechnology.
Business Model Characteristics
The company depends on clinical progress, regulatory steps, and the ability to create value in CNS medicine.
Position Within the Biotechnology Landscape
NRX is a high-risk CNS name whose valuation is driven by clinical and strategic developments.
Future catalysts
- NRX Pharmaceuticals’s catalysts are NRX-100 / NRX-101 and the CNS / ketamine-related development path, plus any strategic or regulatory update. The company still needs a clean execution step.
Recent news
Similar stocks
Peer names with similar commercial maturity, therapeutic overlap, or catalyst patterns.
Frequently Asked Questions
What is the current stock price of NRX Pharmaceuticals, Inc. (NRXP)?
NRX Pharmaceuticals, Inc. (NRXP) most recently closed at 3.45 USD, a -3.09% move versus the previous session.
What is the market cap of NRX Pharmaceuticals, Inc. (NRXP)?
NRX Pharmaceuticals, Inc. currently has a market capitalization of 167M USD on BioPharmSignal.
What does NRX Pharmaceuticals, Inc. do?
NRX Pharmaceuticals is a neuroscience and psychiatric-care company focused on severe depression and related central nervous system conditions. Its story has centered on hard-to-treat mental-health disorders.
On which exchange is NRXP stock listed?
NRX Pharmaceuticals, Inc. (NRXP) is associated with NASDAQ, United States, Biopharma.
What is NRX-100?
NRX Pharmaceuticals’s catalysts are NRX-100 / NRX-101 and the CNS / ketamine-related development path, plus any strategic or regulatory update.
Which conditions is NRX Pharmaceuticals, Inc. targeting with NRX-100?
NRX Pharmaceuticals, Inc. is associated with neuroscience based on its company overview and current catalyst commentary.
How does NRX Pharmaceuticals, Inc. describe recent progress with NRX-100?
NRX Pharmaceuticals’s catalysts are NRX-100 / NRX-101 and the CNS / ketamine-related development path, plus any strategic or regulatory update.
What is NRX-101?
NRX Pharmaceuticals’s catalysts are NRX-100 / NRX-101 and the CNS / ketamine-related development path, plus any strategic or regulatory update.